Myasthenia gravis presents as a chronic autoimmune disorder. In this condition, the body's immune framework mistakenly targets the nerve cells that control muscular actions. This hindrance leads to muscle weakness, which worsens with activity and remits with rest. Symptoms can vary widely from person to person, but common indicators include ptosis

Famotidine is a histamine H2-receptor antagonist, effectively inhibiting the release of gastric acid. This action contributes to the symptoms of various gastrointestinal disorders, including peptic ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. Famotidine's mechanistic profile exhibits a relatively long half-life, a